title: Dark lumen magnetic resonance enteroclysis in combination with MRI colonography for whole bowel assessment in patients with Crohn's disease: first clinical experience.
abstract: BACKGROUND
  Magnetic resonance enteroclysis (MRE) is a recently introduced imaging technique that assesses the small bowel with similar sensitivity and specificity as the fluoroscopically performed conventional enteroclysis. Magnetic resonance imaging colonography (MRC) seems to be a promising technique for polyp assessment in the colon. In this feasibility study, we evaluated the combination of small bowel MRI with unprepared MRC as an integrative diagnostic approach of the whole bowel in patients with Crohn's disease.
  
  
  METHODS
  Thirty patients with known Crohn's disease were prospectively examined. No particular colonic preparation was applied. Applying the dark lumen technique in all patients, MRE and MRC were performed within 1 session using an integrative examination protocol. T2-weighted and contrast-enhanced T1-weighted sequences were acquired. Inflammation assessment (grades 0 to 2) of the colon was compared with conventional colonoscopy in 29 patient and with surgery in 1 patient. The entire colon was graded fair to good distended in all patients. In 11 of 210 evaluated colonic segments, feces hindered an adequate intraluminal bowel assessment. Twenty-three of 30 patients had complete colonoscopy as the gold standard. In 7 patients, complete colonoscopy could not be performed because of an inflamed stenosis.
  
  
  RESULTS
  Correct grading of colonic inflammation was performed with 55.1% sensitivity and 98.2% specificity in all segments. Considering only more extensive inflammation (grade 2), the sensitivity of MRC increased to 70.2% with a specificity of 99.2%.
  
  
  CONCLUSIONS
  The combination of MRE and MRC could improve the diagnostic value of abdominal MRI evaluation in patients with Crohn's disease. However, MRC can not replace conventional colonoscopy in subtle inflammation assessment.
authors.affiliation: Department of Radiology, University Hospital Regensburg, Regensburg, Germany. schreyer@klinik.uni-r.de
authors.forename: Andreas G
authors.initials: AG
authors.lastname: Schreyer
authors.forename: Stefan
authors.initials: S
authors.lastname: Gölder
authors.forename: Karl
authors.initials: K
authors.lastname: Scheibl
authors.forename: Markus
authors.initials: M
authors.lastname: Völk
authors.forename: Markus
authors.initials: M
authors.lastname: Lenhart
authors.forename: Antje
authors.initials: A
authors.lastname: Timmer
authors.forename: Jürgen
authors.initials: J
authors.lastname: Schölmerich
authors.forename: Stefan
authors.initials: S
authors.lastname: Feuerbach
authors.forename: Gerhard
authors.initials: G
authors.lastname: Rogler
authors.forename: Hans
authors.initials: H
authors.lastname: Herfarth
authors.forename: Johannes
authors.initials: J
authors.lastname: Seitz
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003106:Colon / Q000473:pathology*; D003287:Contrast Media; D003424:Crohn Disease / Q000473:pathology*; D005240:Feasibility Studies; D005260:Female; D019786:Gadolinium DTPA; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007421:Intestine, Small / Q000473:pathology*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012680:Sensitivity and Specificity
chemical_list: D003287:Contrast Media; D019786:Gadolinium DTPA